Background: Multidrug-resistant Escherichia coli (MDR E. coli) has become a major public health concern in Sudan and many countries, causing failure in treatment with consequent huge health burden. Objectives: To determine the prevalence and susceptibility of MDR E. coli isolated from patients in hospitals at Khartoum State. Methods: Between May to August 2011, E. coli (n = 232) isolated from clinical specimens, identified, tested their antimicrobials susceptibility and screened for extend spectrum â-lactamase production as per standard methods. Results: Of the 232 E. coli isolates, the majority were from urine (65.1%). MDR E. coli were present in 214 (92.2%). Of these, the resistance rates were recorded to: amoxicillin 97.7%, cefuroxime 92.5%, trimethoprim-sulfamethoxazole 88.3%, tetracycline 77.1%, nalidixic acid 72%, ceftriaxone 64%, ciprofloxacin 58.4%, ofloxacin 55.1%, amoxicillin-clavulanate 50.4%, ceftazidime, gentamicin 35% each, nitrofurantoin 22.4%, chloramphenicol, tobramicin 18.2% each and amikacin 1.9%. Overall MDR E. coli, 53.3% were resistant to > 7 antimicrobial agents and ESBL was detected in 32.7%. Isolates from males were more resistant than those from females (p < 0.05). Conclusions: Drug-resistance surveillance and epidemiological analysis of patient data is need periodically and can be informative for appropriate management of antimicrobial resistance.
Introduction
Escherichia coli (E. coli) is a common pathogen linked with community-associated as well as nosocomial infections 1, 2 . In the last few years, the emergence and wide dissemination of E. coli strains showing resistance to broad-spectrum of antimicrobial agents has been reported 1, 3, 6 . Emergence of resistance to multiple antimicrobial agents in pathogenic bacteria has become a significant public health threat as there are fewer, or even sometimes no, effective antimicrobial agents available for infections caused by these bacteria [3] [4] [5] [6] [7] . According to the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC), multi-drug resistant (MDR) is defined as non-susceptibility to at least one agent in three or more antimicrobial categories 4 . MDR bacteria are the principal cause of failure in the treatment of infectious diseases, resulting in increases in the term and magnitude of morbidity, higher rates of mortality, and a greater health cost burden 9, 10 . However, recently researchers have been investigated the activity of non-antimicrobial agents such as proanthocyanidin to prevent MDR bacterial infections 29 . Multi-drug resistant E. coli are widely distributed in hospitals and are increasingly being isolated from community. Thus, it is urgent need to find out new antimicrobial agents 8, 10, 11 . However, new families of antimicrobial agents have a short life expectancy 11 . Several monitoring programmes have been initiated to generate baseline data about the prevalence of MDR in different bacterial species, including E. coli 8, 12 . Many studies from Europe 7 and USA 6, 13 have investigated MDR among E. coli isolates. Most bacterial isolates from Asian and African countries have shown high MDR rates [14] [15] [16] [17] [18] . In Sudan, limited data are currently available on the prevalence of MDR amongst significant bacterial isolates 19, 20 . . MDR E. coli was defined as nonsusceptibility to at least one agent in three or more antimicrobial categories 4 .
Extend spectrum â -l a c t a m a s e production All E. coli isolates recognizing reduced susceptibility to ceftazidime and ceftriaxone they were screened for ESBLs production by the double-disk synergy test according to CLSI recommendations 23 . In this test, the organism is swabbed onto a MuellerHinton agar plate. A susceptibility disk containing amoxicillin-clavulanate is placed in the center of the plate, and disks containing ceftazidime and cefotaxime are placed 30 mm (center to center) from the amoxicillin-clavulanate disk. A clear extension of the edge of the inhibition zone of cephalosporin towards amoxicillin-clavulanate disk is interpreted as positive for ESBL production 24 .
Statistical analysis
All outcome data were analyzed using Statistical Package for Social Sciences (SPSS; Version10.0). The differences between resistance patterns of E. coli strains were determined using Independent samples T-Test and One-Way Analysis of Variance (ANOVA). All p-values were based on 2-tailed tests of significance where p < 0.05 is considered statistically significant.
Results
The prevalence of E. coli recovered from various clinical specimens (232) collected from different hospitals in Khartoum State is shown in Figure 1 . Urine (65.1%) and wound (22%) specimens represented the majority of specimens. The isolates were obtained from all aged groups: 138 (59.5%) were females and 94 (40.5%) were males. Of the total number of isolates, 180 (77.6 %) were obtained from adult patients. Figure 2 . The resistance rates of isolates to ceftazidime, ceftriaxone and chloramphenicol were significantly higher (p < 0.05) in Khartoum hospital than other hospitals. The resistance rates of isolates to ciprofloxacin and ofloxacin were found significantly higher in Khartoum and Khartoum North than Soba and Omdurman hospitals (p < 0.05) (table 1). But the resistance rates for nitrofurantoin, tetracycline, trimethoprim-sulfamethoxazole, were found significantly higher in isolates from Khartoum and Omdurman hospitals than isolates from Soba and Khartoum North hospitals (p < 0.05). The resistance rates of isolates to gentamicin were found high in Soba hospital but low resistance rates were observed to chloramphenicol (table 1). 
Figure 2: Distribution of MDR E. coli (n = 214) isolated from different hospitals in

3).
Figure 3: Frequency of MDR E. coli (n = 214) according to its resistance to three or more antimicrobial agents
Frequency of antimicrobial resistance pattern of E. coli by sex and age Table 2 shows the resistant pattern of the 214 MDR E. coli isolated from males and females. Isolates from males were showed higher resistance rates than those from females to ceftazidime (p = 0.023), ceftriaxone (p = 0.004), chloramphenicol (p = 0.005), nalidixic acid (p = 0.002), ofloxacin (p = 0.024), tetracycline (p =0.006) and trimethoprim-sulfamethoxazole (p = 0.02). In contrast, resistance rates to nalidixic acid and ofloxacin were higher in females than males isolates (table 2) . Distribution of MDR E. coli according to age showed no statistical differences between adults and children were observed to the most antimicrobial agents. However, there were significant differences observed in two antimicrobial agents ciprofloxacin (p = 0.02) was higher in adults and chloramphenicol (p = 0.047) was higher in children (table 2) . and elsewhere 3, 6, 25 .
Resistance to fluoroquinolones varies geographically and is an emerging problem in both developed and developing countries. 13, 28 . In the present study, MDR E. coli isolates showed relatively high resistance rates to ofloxacin and ciprofloxacin. This has been hypothesized to be related to the inappropriate use of fluoroquinolones for humans 2 . Also, prolonged use of low dose of the more potent fluoroquinolones such as ciprofloxacin has been shown to be the most significant risk factor for acquisition of resistance 27 . Whilst the third-generation cephalosporins such as ceftriaxone and ceftazidime have been used to treat gram-negative bacterial infections of various body sites 5, 25 , the current study showed high levels of resistance to second and third generation cephalosporins. A possible explanation for the high resistance found might be the presence of ESBL in these strains 18 . Since ESBL mediated resistance to wide range of antimicrobial classes 8, 18 , it is important that routine screening of ESBL in clinical isolates is carried out to prevent widespread of resistant isolates in our hospitals. Like studies elsewhere 7, 15, 25 , our MDR E. coli isolates were found to be effective against aminoglycoside agents. Amikacin appears to have wider range of activity than tobramicin, gentamicin and other tested antimicrobial agents. The explanation for amikacin is probably the fact that these are very powerful drugs used only in hospital settings and not as first-line therapy. Therefore, they have lower selective pressure due to their restricted use 25 . The emergence of E. coli isolates with different MDR phenotypes, involving co-resistance to three or more unrelated families of antimicrobial agents, has been previously reported by others and is considered a serious health concern 1, 3, 6 . Similar to reports by others 3, 7, 16 , the current study expressed high resistance rates to different classes of antimicrobial agents. Almost our MDR E. coli isolates were found to be multi-resistant to the commonly used antimicrobials agents of amoxicillin, cefuroxime, trimethoprim-sulfamethoxazole tetracycline, and nalidixic acid. These resistance profiles were common and could be accounted for by a number of known acquired resistance genes 3 . Since proanthocyanidin is a non-antimicrobial agents used for the prevention of urinary tract infection caused by susceptible E. coli strains via inhibiting Pfimbriated adhesion to uroepithelial cells 30 . Recently, Gupta et al. 29 have been obser ved that proanthocyanidin prevent also adhesion of most MDR E. coli strains to the uroepithelial cells.
In the present study, MDR E. coli from Khartoum hospital had high resistance rates to most of the antimicrobial agents. Also, our report showed a variable difference in antimicrobial resistance of MDR E. coli between each hospital in Khartoum State. MDR may vary according to geographical regions. Although previous use of antimicrobials may be involved in the regional differences of antimicrobial resistance, consider other factors such as the patients' characteristics or sampling bias and the social and geological factors that attribute to this variation of MDR as previously described 26 . Largescale, local studies, hospital and departmental data, therefore, are required to understand drug resistance in each setting.
In the current study, MDR E. coli isolates from males were more likely to have resistance to antimicrobial agents than those from females. Similar findings have been described worldwide 6, 7, 13, 25 . The resistance pattern was somewhat affected in gender, but that definitely depended on the site of infection 25 and clinical parameters of the population investigated 26 . No statistical differences (p = 0.249) were found in antimicrobial resistance between adults and children. Similar results were reported by Boyd et al. (2008) . However, it is important to emphasize on the high prevalence of fluoroquinolones resistance in isolates from children which is not recommended for treatment of pediatric patients.
Conclusion
This study concluded that MDR E. coli is escalating in Khartoum State (92.2%) compared to previous surveys (58%). Multiple resistances to antimicrobial drugs among E. coli isolates complicate therapeutic management of infections. Drug-resistance surveillance and epidemiological analysis of patient data is needed periodically and can be informative for appropriate management of antimicrobial resistance. Understanding the molecular basis of resistance acquisition and transmission can contribute to the development of new strategies to combat this phenomenon.
